GMP News
08/08/2016
How to perform Temperature Mapping
如何实施温度分布试验
In a recent blog of the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA), the inspectorate looks at temperature mapping. It seems that "some companies are unclear as to what is expected of them to comply with this requirement in the GDP Guidelines", the Agency says.
在英国药监最近的博文中，检查员查看了温度分布试验。当局说，看起来“有些公司并不清楚如何做来符合GDP指南里的这些要求”。
The requirement itself is defined in the GDP Guidelines Chapter 3.2.1: "An initial temperature mapping exercise should be carried out on the storage area before use, under representative conditions." The results of this mapping should be used to place monitoring devices at areas that experience the most temperature differences and the hot and cold spots. Any potential area that may be unsuitable to store medicines should be identified. Therefore, mapping should be performed before stock is stored. However, the MHRA also recommends to repeat the mapping when the storage area is operating (taking into account seasonal variations).
要求本身是在GDP指南第3.2.1里定义的，“存贮区域在使用之前要在代表性条件下进行初始温度分布测试”。此分布测试的结果应被用来布置该区域的监测装置，所布的监测点应有最大的温度差异，应包括最高和最低温度点。所有可能不适用存贮药品的区域都要被识别出来。因此，分布试验的实施应该在用于存放药品之前。但是，MHRA也建议在存贮区域运行中时重复温度分布试验（考虑季节波动）。
What to consider: 要考虑些什么：
Please also see the MHRA Inspectorate Blog "Temperature mapping – an introduction".
更多信息参见MHRA博文。
| 欢迎光临 药群论坛 (http://yaoqun.net/) | Powered by Discuz! X3.2 |